A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 | Last   [Sort alphabetically]   [Restore default list]

  Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
Showing 1 - 200 of 253 Journals sorted by number of followers
Nature Reviews Drug Discovery     Full-text available via subscription   (Followers: 324)
International Journal of Drug Policy     Hybrid Journal   (Followers: 253)
Journal of Clinical Oncology     Hybrid Journal   (Followers: 240)
Journal of Medicinal Chemistry     Hybrid Journal   (Followers: 154)
Journal of Pharmaceutical Sciences     Hybrid Journal   (Followers: 152)
Drugs     Full-text available via subscription   (Followers: 144)
Advanced Drug Delivery Reviews     Hybrid Journal   (Followers: 94)
Pharmaceutical Research     Hybrid Journal   (Followers: 93)
European Journal of Pharmaceutical Sciences     Hybrid Journal   (Followers: 85)
Drug Safety     Full-text available via subscription   (Followers: 82)
Annals of Pharmacotherapy     Hybrid Journal   (Followers: 56)
Biomaterials     Hybrid Journal   (Followers: 55)
Clinical Pharmacology & Therapeutics     Hybrid Journal   (Followers: 45)
Regulatory Toxicology and Pharmacology     Hybrid Journal   (Followers: 41)
Annual Review of Pharmacology and Toxicology     Full-text available via subscription   (Followers: 38)
Journal of Controlled Release     Hybrid Journal   (Followers: 37)
International Journal of Pharmaceutics     Hybrid Journal   (Followers: 37)
Clinical Therapeutics     Hybrid Journal   (Followers: 34)
European Journal of Pharmaceutics and Biopharmaceutics     Hybrid Journal   (Followers: 34)
Pharmacoepidemiology and Drug Safety     Hybrid Journal   (Followers: 33)
British Journal of Clinical Pharmacology     Hybrid Journal   (Followers: 31)
Journal of Pharmacy and Pharmacology     Full-text available via subscription   (Followers: 31)
Drug Development and Industrial Pharmacy     Hybrid Journal   (Followers: 29)
Clinical Pharmacokinetics     Full-text available via subscription   (Followers: 28)
PharmacoEconomics     Full-text available via subscription   (Followers: 26)
Critical Reviews in Toxicology     Hybrid Journal   (Followers: 25)
AAPS Journal     Hybrid Journal   (Followers: 25)
Journal of Clinical Psychopharmacology     Hybrid Journal   (Followers: 24)
International Journal of Pharmacy Practice     Full-text available via subscription   (Followers: 24)
Toxicology and Applied Pharmacology     Hybrid Journal   (Followers: 24)
Chemical Research in Toxicology     Hybrid Journal   (Followers: 22)
Journal of Pharmacokinetics and Pharmacodynamics     Hybrid Journal   (Followers: 22)
Journal of Pain & Palliative Care Pharmacotherapy     Hybrid Journal   (Followers: 21)
Trends in Pharmacological Sciences     Full-text available via subscription   (Followers: 20)
Journal of Clinical Pharmacology     Hybrid Journal   (Followers: 20)
Journal of Applied Toxicology     Hybrid Journal   (Followers: 19)
Pharmaceutical Development and Technology     Hybrid Journal   (Followers: 19)
American Journal of Cardiovascular Drugs     Hybrid Journal   (Followers: 19)
Clinical Trials     Hybrid Journal   (Followers: 18)
Toxicology     Hybrid Journal   (Followers: 18)
Journal of Pharmaceutical and Biomedical Analysis     Hybrid Journal   (Followers: 18)
Clinical Toxicology     Hybrid Journal   (Followers: 18)
International Journal of Toxicology     Hybrid Journal   (Followers: 17)
Journal of Clinical Pharmacy and Therapeutics     Hybrid Journal   (Followers: 17)
Critical Reviews in Clinical Laboratory Sciences     Hybrid Journal   (Followers: 16)
Journal of Natural Products     Hybrid Journal   (Followers: 16)
Pharmaceutical Statistics     Hybrid Journal   (Followers: 15)
Toxicology Letters     Hybrid Journal   (Followers: 15)
Journal of Pharmacy Practice     Hybrid Journal   (Followers: 15)
Psychopharmacology     Hybrid Journal   (Followers: 15)
Basic & Clinical Pharmacology & Toxicology     Hybrid Journal   (Followers: 14)
Cardiovascular Drugs and Therapy     Hybrid Journal   (Followers: 14)
European Journal of Clinical Pharmacology     Hybrid Journal   (Followers: 14)
Current Medicinal Chemistry     Hybrid Journal   (Followers: 13)
American Journal of Therapeutics     Hybrid Journal   (Followers: 13)
Drug and Chemical Toxicology     Hybrid Journal   (Followers: 13)
Journal of the American Pharmacists Association     Full-text available via subscription   (Followers: 13)
Drug Metabolism and Disposition     Hybrid Journal   (Followers: 13)
Clinical Research and Regulatory Affairs     Hybrid Journal   (Followers: 12)
Drug Discovery Today: Technologies     Full-text available via subscription   (Followers: 12)
Seminars in Hematology     Hybrid Journal   (Followers: 12)
Journal of Oncology Pharmacy Practice     Hybrid Journal   (Followers: 12)
Journal of Psychopharmacology     Hybrid Journal   (Followers: 11)
Biopharmaceutics and Drug Disposition     Hybrid Journal   (Followers: 11)
Current Pharmaceutical Design     Hybrid Journal   (Followers: 11)
Drug Development Research     Hybrid Journal   (Followers: 11)
Toxicology in Vitro     Hybrid Journal   (Followers: 11)
Seminars in Oncology Nursing     Full-text available via subscription   (Followers: 10)
Biochemical Pharmacology     Hybrid Journal   (Followers: 10)
Journal of Pharmacology and Experimental Therapeutics     Hybrid Journal   (Followers: 10)
Journal of Separation Science     Hybrid Journal   (Followers: 10)
CNS Drugs     Full-text available via subscription   (Followers: 10)
Current Pharmaceutical Biotechnology     Hybrid Journal   (Followers: 10)
Journal of Medical Marketing     Hybrid Journal   (Followers: 10)
Drugs & Aging     Full-text available via subscription   (Followers: 10)
European Neuropsychopharmacology     Hybrid Journal   (Followers: 9)
Food Additives & Contaminants Part A     Hybrid Journal   (Followers: 9)
Environmental Toxicology and Pharmacology     Hybrid Journal   (Followers: 9)
Medicinal Chemistry     Hybrid Journal   (Followers: 9)
Biometrical Journal     Hybrid Journal   (Followers: 9)
Drugs & Therapy Perspectives     Full-text available via subscription   (Followers: 9)
Prescriber     Hybrid Journal   (Followers: 9)
ChemMedChem     Hybrid Journal   (Followers: 9)
Current Opinion in Pharmacology     Hybrid Journal   (Followers: 9)
European Journal of Pharmacology     Hybrid Journal   (Followers: 8)
Clinical Drug Investigation     Full-text available via subscription   (Followers: 8)
Inhalation Toxicology     Hybrid Journal   (Followers: 8)
Antiviral Research     Hybrid Journal   (Followers: 8)
Drug Metabolism Reviews     Hybrid Journal   (Followers: 8)
Progress in Neuro-Psychopharmacology and Biological Psychiatry     Hybrid Journal   (Followers: 8)
Human & Experimental Toxicology     Hybrid Journal   (Followers: 8)
Drug Delivery     Open Access   (Followers: 8)
BioDrugs     Full-text available via subscription   (Followers: 8)
Frontiers in Drug Design & Discovery     Hybrid Journal   (Followers: 8)
Expert Review of Pharmacoeconomics & Outcomes Research     Full-text available via subscription   (Followers: 8)
Experimental and Clinical Psychopharmacology     Full-text available via subscription   (Followers: 7)
Toxicology Mechanisms and Methods     Hybrid Journal   (Followers: 7)
Journal of Pharmacological and Toxicological Methods     Hybrid Journal   (Followers: 7)
Clinical and Experimental Pharmacology and Physiology     Hybrid Journal   (Followers: 7)
Scandinavian Journal of Clinical and Laboratory Investigation     Hybrid Journal   (Followers: 7)
Epilepsy Research     Hybrid Journal   (Followers: 7)
Toxicology and Industrial Health     Hybrid Journal   (Followers: 6)
Journal of Veterinary Pharmacology and Therapeutics     Hybrid Journal   (Followers: 6)
Skin Pharmacology and Physiology     Full-text available via subscription   (Followers: 6)
Journal of Cardiovascular Pharmacology     Hybrid Journal   (Followers: 6)
AAPS PharmSciTech     Hybrid Journal   (Followers: 6)
Current Drug Discovery Technologies     Hybrid Journal   (Followers: 6)
Current Drug Delivery     Hybrid Journal   (Followers: 6)
Current Therapeutic Research     Open Access   (Followers: 6)
Expert Review of Cardiovascular Therapy     Full-text available via subscription   (Followers: 6)
Neuropharmacology     Hybrid Journal   (Followers: 5)
Current Drug Metabolism     Hybrid Journal   (Followers: 5)
Fitoterapia     Hybrid Journal   (Followers: 5)
Expert Review of Molecular Diagnostics     Full-text available via subscription   (Followers: 5)
Expert Review of Anti-infective Therapy     Full-text available via subscription   (Followers: 5)
Anti-Infective Agents     Hybrid Journal   (Followers: 5)
Toxicon     Hybrid Journal   (Followers: 5)
Medicinal Research Reviews     Hybrid Journal   (Followers: 5)
Investigational New Drugs     Hybrid Journal   (Followers: 5)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry     Hybrid Journal   (Followers: 5)
Current Cancer Therapy Reviews     Hybrid Journal   (Followers: 5)
Reviews of Physiology, Biochemistry and Pharmacology     Hybrid Journal   (Followers: 4)
Planta Medica     Hybrid Journal   (Followers: 4)
Current Vascular Pharmacology     Hybrid Journal   (Followers: 4)
Pharmaceutical Medicine     Full-text available via subscription   (Followers: 4)
Journal of Child and Adolescent Psychopharmacology     Hybrid Journal   (Followers: 4)
CNS Drug Reviews     Open Access   (Followers: 4)
Inpharma Weekly     Full-text available via subscription   (Followers: 4)
Journal of Labelled Compounds and Radiopharmaceuticals     Hybrid Journal   (Followers: 4)
Immunopharmacology and Immunotoxicology     Hybrid Journal   (Followers: 4)
International Journal of Pharmaceutical and Healthcare Marketing     Hybrid Journal   (Followers: 4)
Inflammation Research     Hybrid Journal   (Followers: 4)
Cancer Chemotherapy and Pharmacology     Hybrid Journal   (Followers: 4)
International Journal of Neuropsychopharmacology     Open Access   (Followers: 3)
Pharmacology & Therapeutics     Hybrid Journal   (Followers: 3)
Physiology International     Full-text available via subscription   (Followers: 3)
Cardiovascular Therapeutics     Open Access   (Followers: 3)
ASSAY and Drug Development Technologies     Hybrid Journal   (Followers: 3)
Pharmacopsychiatry     Hybrid Journal   (Followers: 3)
Chemotherapy     Full-text available via subscription   (Followers: 3)
Therapeutic Drug Monitoring     Hybrid Journal   (Followers: 3)
Current Drug Therapy     Hybrid Journal   (Followers: 3)
Research in Social and Administrative Pharmacy     Hybrid Journal   (Followers: 3)
PharmacoEconomics & Outcomes News     Full-text available via subscription   (Followers: 3)
Journal of Aerosol Medicine and Pulmonary Drug Delivery     Hybrid Journal   (Followers: 3)
Journal of Ethnopharmacology     Hybrid Journal   (Followers: 3)
Drug Resistance Updates     Hybrid Journal   (Followers: 3)
Journal of Infection and Chemotherapy     Hybrid Journal   (Followers: 3)
Journal of Cardiovascular Pharmacology and Therapeutics     Hybrid Journal   (Followers: 3)
Current Pharmacogenomics and Personalized Medicine     Hybrid Journal   (Followers: 3)
Acta Pharmacologica Sinica     Hybrid Journal   (Followers: 3)
Microbial Drug Resistance     Hybrid Journal   (Followers: 3)
Frontiers in Medicinal Chemistry     Hybrid Journal   (Followers: 3)
Human Psychopharmacology Clinical and Experimental     Hybrid Journal   (Followers: 3)
Journal of Pain Management & Medicine     Open Access   (Followers: 2)
BMC Pharmacology     Open Access   (Followers: 2)
The Brown University Psychopharmacology Update     Hybrid Journal   (Followers: 2)
International Clinical Psychopharmacology     Hybrid Journal   (Followers: 2)
Canadian Journal of Physiology and Pharmacology     Hybrid Journal   (Followers: 2)
Journal of Drug Targeting     Hybrid Journal   (Followers: 2)
Inflammopharmacology     Hybrid Journal   (Followers: 2)
Journal of Inflammation     Open Access   (Followers: 2)
Fundamental & Clinical Pharmacology     Hybrid Journal   (Followers: 2)
Behavioural Pharmacology     Hybrid Journal   (Followers: 2)
Vascular Pharmacology     Hybrid Journal   (Followers: 2)
Pulmonary Pharmacology & Therapeutics     Hybrid Journal   (Followers: 2)
Biomedicine & Pharmacotherapy     Full-text available via subscription   (Followers: 2)
Clinical Neuropharmacology     Hybrid Journal   (Followers: 2)
Drugs in R & D     Full-text available via subscription   (Followers: 2)
International Immunopharmacology     Hybrid Journal   (Followers: 2)
Pharmacology Biochemistry and Behavior     Hybrid Journal   (Followers: 2)
Letters in Drug Design & Discovery     Hybrid Journal   (Followers: 2)
Archiv der Pharmazie     Hybrid Journal   (Followers: 2)
Pharmacological Reviews     Hybrid Journal   (Followers: 2)
Molecular Pharmacology     Hybrid Journal   (Followers: 2)
Journal of Microencapsulation: Microcapsules, Liposomes, Nanoparticles, Microcells, Microspheres     Hybrid Journal   (Followers: 2)
Toxicological & Environmental Chemistry     Hybrid Journal   (Followers: 2)
Particulate Science and Technology: An International Journal     Hybrid Journal   (Followers: 1)
Pharmacological Research     Hybrid Journal   (Followers: 1)
Current Enzyme Inhibition     Hybrid Journal   (Followers: 1)
Journal of Neuroimmune Pharmacology     Hybrid Journal   (Followers: 1)
Current Pharmaceutical Analysis     Hybrid Journal   (Followers: 1)
Current Neuropharmacology     Hybrid Journal   (Followers: 1)
Pharmacogenetics and Genomics     Hybrid Journal   (Followers: 1)
Journal of Texture Studies     Hybrid Journal   (Followers: 1)
Pharmaceutical Biology     Open Access  
Journal of Liposome Research     Hybrid Journal  
Toxin Reviews     Hybrid Journal  
Kaohsiung Journal of Medical Sciences     Open Access  
Redox Report     Open Access  
Pharmacology     Full-text available via subscription  
Pharmaceutical Chemistry Journal     Hybrid Journal  
NeuroMolecular Medicine     Hybrid Journal  
Journal of Ocular Pharmacology and Therapeutics     Hybrid Journal  
Harm Reduction Journal     Open Access  
Current Nanoscience     Hybrid Journal  
Infectious Disorders - Drug Targets     Hybrid Journal  
Current Bioactive Compounds     Hybrid Journal  
Cancer Biotherapy & Radiopharmaceuticals     Hybrid Journal  
Autonomic & Autacoid Pharmacology     Hybrid Journal  

        1 2 3 | Last   [Sort alphabetically]   [Restore default list]

Similar Journals
Journal Cover
The Pink Sheet Daily
Number of Followers: 5  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 1554-4036
Published by Informa plc Homepage  [9 journals]
  • Dissecting Piramal’s Damages Award In Sensipar Case

    • Free pre-print version: Loading...

      Abstract: A legal expert details how Piramal Healthcare could turn the tables and secure damages in the litigation pertaining to its...     Related Stories
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems
      Medicare CED Update Targets Study ‘Efficiency,’ But May Not Ease Data Collection Burden 
      PubDate: Tue, 04 Oct 2022 18:01:31 GMT
       
  • US FDA Begins Implementing New User Fee Programs, But What About The
           Actual Fees'

    • Free pre-print version: Loading...

      Abstract: Sponsors looking to file applications continue to wait for the new user fees to be announced, as details of the...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems
      Medicare CED Update Targets Study ‘Efficiency,’ But May Not Ease Data Collection Burden 
      PubDate: Tue, 04 Oct 2022 17:30:10 GMT
       
  • The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious
           Problems

    • Free pre-print version: Loading...

      Abstract: Some filling lines and API plants fared poorly in post-pandemic inspections, with shortfalls identified in sterility assurance and impurity control...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      Medicare CED Update Targets Study ‘Efficiency,’ But May Not Ease Data Collection Burden 
      PubDate: Tue, 04 Oct 2022 15:43:48 GMT
       
  • EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group

    • Free pre-print version: Loading...

      Abstract: Industry body Medicines for Europe is calling for pharmaceutical manufacturers to be excluded from energy restriction policies for winter 2022...     Related Stories
      EMA Raises Industry Fees For EU Pharmacovigilance Services
      US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No Tecfidera As Biogen Loses Bid
      UK Avoids ?Cliff Edge? By Extending EU Drug Approval Reliance Procedure 
      PubDate: Tue, 04 Oct 2022 12:00:00 GMT
       
  • EMA Raises Industry Fees For EU Pharmacovigilance Services

    • Free pre-print version: Loading...

      Abstract: Companies using the European Medicines Agency’s drug safety services will be paying more from 3 October.     Related Stories
      EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
      US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No Tecfidera As Biogen Loses Bid
      UK Avoids ?Cliff Edge? By Extending EU Drug Approval Reliance Procedure 
      PubDate: Tue, 04 Oct 2022 10:07:27 GMT
       
  • Medicare CED Update Targets Study ‘Efficiency,’ But May Not
           Ease Data Collection Burden

    • Free pre-print version: Loading...

      Abstract: It?s not clear that the proposed revisions and additions to the Centers for Medicare and Medicaid Services’ existing coverage with...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems 
      PubDate: Mon, 03 Oct 2022 23:00:00 GMT
       
  • US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No
           Tecfidera As Biogen Loses Bid

    • Free pre-print version: Loading...

      Abstract: Teva’s carve-out fight with GSK over generic Coreg will see the Solicitor General weigh in. Amgen and Juno’s patent petitions remain...     Related Stories
      EMA Raises Industry Fees For EU Pharmacovigilance Services
      EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
      UK Avoids ?Cliff Edge? By Extending EU Drug Approval Reliance Procedure 
      PubDate: Mon, 03 Oct 2022 22:59:27 GMT
       
  • In-Person US FDA Meetings Returning' Agency Will Support Those Events
           At HQ

    • Free pre-print version: Loading...

      Abstract: A workshop broadcast from White Oak was a shift from the fully virtual meetings held since the height of the...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems 
      PubDate: Mon, 03 Oct 2022 19:45:42 GMT
       
  • US FDA Still Hasn’t Decided Who Will Be Final Arbiter On Approval Status
           For Covis’ Makena

    • Free pre-print version: Loading...

      Abstract: With two weeks to go before hearing on whether the preterm birth prevention drug can stay on the market or...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems 
      PubDate: Mon, 03 Oct 2022 18:43:27 GMT
       
  • UK Avoids 'Cliff Edge' By Extending EU Drug Approval
           Reliance Procedure

    • Free pre-print version: Loading...

      Abstract: The UK drugs regulator says it needs to make sure that companies do not “deprioritize” GB approval applications while a...     Related Stories
      EMA Raises Industry Fees For EU Pharmacovigilance Services
      EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
      US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No Tecfidera As Biogen Loses Bid 
      PubDate: Mon, 03 Oct 2022 12:59:48 GMT
       
  • €5m Initiative To Help EU Member States Cooperate On Trial Safety
           Assessments

    • Free pre-print version: Loading...

      Abstract: An EU funded project is to help national competent authorities cooperate on the safety assessment of clinical trials as required...     Related Stories
      EMA Raises Industry Fees For EU Pharmacovigilance Services
      EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
      US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No Tecfidera As Biogen Loses Bid 
      PubDate: Mon, 03 Oct 2022 12:37:01 GMT
       
  • New EU Filings

    • Free pre-print version: Loading...

      Abstract: Santhera Pharmaceuticals’ vamorolone for treating Duchenne muscular dystrophy is among the latest medicines that have been submitted for review for...     Related Stories
      RWE By The Numbers: Breaking Down FDA?s Use Over The Years 
      PubDate: Mon, 03 Oct 2022 10:30:00 GMT
       
  • Stakeholders Must ‘Fully Engage’ If WHO’s Medicines
           Access Platform Is To Succeed

    • Free pre-print version: Loading...

      Abstract: Delegates at the European Health Forum Gastein outlined the challenges facing an international effort to improve access to costly new...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems 
      PubDate: Mon, 03 Oct 2022 04:40:36 GMT
       
  • Amylyx Relyvrio: Pricing, Compounding, And The Shadow Of Makena

    • Free pre-print version: Loading...

      Abstract: The new ALS product is a fixed-dose combo of two ingredients – sodium phenylbutyrate and taurursodiol – that some patients...     Related Stories
      EMA Raises Industry Fees For EU Pharmacovigilance Services
      EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
      US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No Tecfidera As Biogen Loses Bid 
      PubDate: Fri, 30 Sep 2022 23:16:00 GMT
       
  • Keeping Track: US FDA Clears Santen’s Omlonti, Fennec’s Pedmark;
           Lilly’s Retevmo Adds Tumor-Agnostic Claim

    • Free pre-print version: Loading...

      Abstract: The latest drug approval news and highlights from the Pink Sheet’s US FDA Performance Tracker     Related Stories
      EMA Raises Industry Fees For EU Pharmacovigilance Services
      EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
      US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No Tecfidera As Biogen Loses Bid 
      PubDate: Fri, 30 Sep 2022 22:30:00 GMT
       
  • China Drug Price Negotiations: Another Race To The Bottom?

    • Free pre-print version: Loading...

      Abstract: With the fourth quarter just around the corner, China?s closely-watched annual drug reimbursement and prices negotiations are entering a key...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems 
      PubDate: Fri, 30 Sep 2022 15:02:00 GMT
       
  • Biogen/Eisai’s Lecanemab Suggests A New Model For Accelerated
           Approval In The US

    • Free pre-print version: Loading...

      Abstract: Why not wait for the confirmatory trial to read out before approval, at least in the context of an especially...     Related Stories
      Honoring R&D Excellence: Citeline Awards Nominations Are Open 
      PubDate: Fri, 30 Sep 2022 13:10:00 GMT
       
  • Recent And Upcoming FDA Advisory Committee Meetings

    • Free pre-print version: Loading...

      Abstract: Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.      Related Stories
      EMA Raises Industry Fees For EU Pharmacovigilance Services
      EU Drug Supply In Jeopardy Without Energy Support, Warns Industry Group
      US Supreme Court Preview: ‘Skinny’ Labels, FTC, And FCA – But No Tecfidera As Biogen Loses Bid 
      PubDate: Fri, 30 Sep 2022 13:07:00 GMT
       
  • Pink Sheet Podcast: Drug Fix: ALS Drug Cleared, Lecanemab’s Hopeful
           Alzheimer’s Data, CMS’ Price Negotiation Needs

    • Free pre-print version: Loading...

      Abstract: Pink Sheet reporters and editors discuss the newly approved ALS drug Relyvrio, the promising data on the Alzheimer’s drug lecanemab...     Related Stories
      Dissecting Piramal’s Damages Award In Sensipar Case
      US FDA Begins Implementing New User Fee Programs, But What About The Actual Fees?
      The Quality Lowdown: No Longer Stoppered By Pandemic, US FDA Finds Serious Problems 
      PubDate: Fri, 30 Sep 2022 13:06:00 GMT
       
  • Novel Brain Penetrant For Treating X-ALD Among Raft Of New EU Filings

    • Free pre-print version: Loading...

      Abstract: Investigational products from Minoryx and a host of other companies targeting a range of diseases are now under review by...     Related Stories
      AB Science & Daiichi Try Their Luck Again With EU Filings
      Evusheld: UK Urged To Use RWD To Give Clinically Vulnerable Early Access To COVID-19 Treatment
      Regulatory Flexibility: US FDA Approves Amylyx’s Relyvrio For ALS Despite ‘Degree Of Residual Uncertainty’ 
      PubDate: Fri, 30 Sep 2022 12:44:50 GMT
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 44.210.237.158
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-